Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Atherosclerosis. 2019 May 30;287:38–45. doi: 10.1016/j.atherosclerosis.2019.05.016

Figure 4:

Figure 4:

Differential expression of FAS and cFAS in murine tissue-specific liver and skeletal muscle FAS knockdowns.

(A) FAS protein content from liver homogenates of +/+, db/db, fasL−/−, and fasM−/− mice were evaluated using Western blotting. (A and B) fasL−/− mice demonstrated significantly less FAS in the liver, while db/db mice demonstrated significantly higher FAS in the liver. *p<0.05. Error bars represent the SEM. (C) FAS protein content from anterior tibialis muscle homogenates from the same mouse groups was also evaluated using Western blotting. (C and D) fasM−/− mice showed significantly less FAS in the muscle tissue, and db/db mice also showed significantly higher FAS in the muscle. *p<0.05. Error bars represent the SEM. (E) Whole serum was collected from all mouse groups, and cFAS was then evaluated using Western blot. fasL−/− mice had significantly less cFAS compared to +/+ and fasM−/−. db/db mice had significantly higher cFAS compared to all other mouse groups. **p<0.01. Error bars represent the SEM. GAPDH blot was used as loading control for all Western blots.